Asset Details
Do you wish to reserve the book?
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
Do you wish to request the book?
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
2021
Overview
Psoriatic arthritis (PsA) is a chronic inflammatory disease belonging to the family of spondyloarthropathies (SpA). PsA commonly aggravates psoriasis of the skin and frequently manifests as an oligoarthritis with axial skeletal involvement and extraarticular manifestations including dactylitis, enthesitis, and uveitis. The weight of genetic predisposition to psoriasis and PsA is illustrated by the concordance rates in monozygotic twins which clearly demonstrate that genomics is insufficient to induce the clinical phenotype. The association of PsA with several single nucleotide polymorphisms (SNPs) at the IL23R locus and the involvement of Th17 cells in the immunopathogenesis of PsA clearly put the IL-23/IL-17 axis in the spotlight. The IL-23 and IL-17 cytokines have a pivotal role in the chronic inflammation of the synovium in PsA and are also prominent in the skin lesions of those with PsA. In this review, we focus on the genetic association of the IL-23/IL-17 axis with PsA and the contribution of these master cytokines in the pathophysiology of the disease, highlighting the main cell types incriminated in PsA and their specific role in the peripheral blood, lesional skin and joints of patients. We then provide an overview of the approved biologic drugs targeting the IL-23/IL-17 axis and discuss the advantages of genetic stratification to enhance personalized therapies in PsA.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Antigens
/ Arthritis, Psoriatic - diagnosis
/ Arthritis, Psoriatic - etiology
/ Arthritis, Psoriatic - metabolism
/ Bones
/ Genetic Predisposition to Disease
/ Genetics
/ Genome-Wide Association Study
/ Genomes
/ Humans
/ IL17
/ IL23
/ Proteins
/ Single-nucleotide polymorphism
/ SNPs (single nucleotide polymorphisms)
/ Synovium
/ therapy
/ Twins
/ Uveitis
